<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="t0005" position="float">
 <label>Table 1</label>
 <caption>
  <p>General Key characteristics and information on Zika and other (arthropod-borne) arboviral diseases worldwide.</p>
 </caption>
 <alt-text id="al0010">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Arbovirus Disease</th>
    <th>Arthropod vector</th>
    <th>Arthropod Virus subtype</th>
    <th>Incubation period, days</th>
    <th>Complications symptoms</th>
    <th>Region Epidemics, year(s)</th>
    <th>Incidence</th>
    <th>Prevalence</th>
    <th>Fatality rate</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Zika viral fever</td>
    <td>
     <italic>Aedes aegypti</italic> &amp; 
     <italic>A. albopticus</italic>
    </td>
    <td>Zika virus (ZKV1,2,3)</td>
    <td>3–7</td>
    <td>Conjunctivitis and joint pain, mother to the baby during pregnancy with microcephaly neurologic and birth defects, Guillain–Barré syndrome syndrome and other poor birth outcomes of babies</td>
    <td>Africa, Southeast Asia and the Pacific Islands, 1954,
     <break/>Central and South America and the Caribbean,
    </td>
    <td>-NA</td>
    <td>1.5 million</td>
    <td>NA</td>
   </tr>
   <tr>
    <td>Dengue hemorrhagic fever
     <break/>Dengue fever
    </td>
    <td>
     <italic>Aedes aegypti</italic>&amp; A 
     <italic>albopictus</italic>
    </td>
    <td>Dengue virus (DENV1,2,3,4)</td>
    <td>2–14</td>
    <td>Shock, internal bleeding, and organ damage</td>
    <td>Tropical and subtropical regions 1800s,</td>
    <td>&lt; 284–528 million infections annually</td>
    <td>&gt; 652,212 DHF
     <break/>67–136 million DF
    </td>
    <td>&lt; 1% with treatment, 1–5% without; about 25% severe cases</td>
   </tr>
   <tr>
    <td>Chikungunya fever</td>
    <td>
     <italic>Aedes aegypti</italic> or 
     <italic>A. albopictus</italic> mosquitoes
    </td>
    <td>Chikungunya virus</td>
    <td>3–7</td>
    <td>Severe and disabling, Joint and muscle pain, joint swelling, or rash</td>
    <td>Africa, Asia, Europe, and the Pacific islands, The Americas on islands in the Caribbean</td>
    <td>NA</td>
    <td>NA</td>
    <td/>
   </tr>
   <tr>
    <td>Rift valley Fever</td>
    <td>
     <italic>Culex tritaeniorhynchus</italic> and 
     <italic>Aedes vexans</italic>
    </td>
    <td>Rift valley virus</td>
    <td>2–6</td>
    <td>Hemorrhagic fever, meningo-encephalitis</td>
    <td>Eastern, Southern, and Western Africa</td>
    <td>NA</td>
    <td>NA</td>
    <td>1% in humans; in pregnant livestock, 100% fetus fatality rate</td>
   </tr>
   <tr>
    <td>West Nile fever</td>
    <td>West Nile virus</td>
    <td>
     <italic>Culex</italic> mosquitoes
    </td>
    <td>2–15</td>
    <td>Swollen lymph nodes, meningitis, encephalitis, acute flaccid paralysis</td>
    <td>North America, Europe, West and Central Asia, Oceania, and Africa, 1937</td>
    <td>NA</td>
    <td>NA</td>
    <td>3–15% in severe cases</td>
   </tr>
   <tr>
    <td>Yellow Fever</td>
    <td>YF virus</td>
    <td>
     <italic>Aedes aegypti</italic> mosquitoes
    </td>
    <td>3–6</td>
    <td>Jaundice, liver damage, recurring fever, gastrointestinal bleeding,</td>
    <td>Tropical and subtropical regions of South America and Africa, 1937</td>
    <td>NA</td>
    <td>NA</td>
    <td>3% in general; 20% chronic cases</td>
   </tr>
   <tr>
    <td>Japanese encephalitis disease</td>
    <td>Japanese encephalitis virus</td>
    <td>
     <italic>JEV1,2,3,4,5</italic>
    </td>
    <td>5–15</td>
    <td>Encephalitis, seizures, paralysis, coma, and long-term brain damage</td>
    <td>Southeast and East Asia</td>
    <td>NA</td>
    <td>NA</td>
    <td>20–30% in encephalitis cases</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
